Antibodies against muscle-specific kinase in juvenile myasthenia gravis

Neuropediatrics

Volumn 34, Issue 2, 2003, Pages 110-111

  Anlar, Banu ^a   Vincent, A ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHOLINERGIC RECEPTOR; PROTEIN KINASE;

CLINICAL ARTICLE; FEMALE; HUMAN; LETTER; MALE; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; ONSET AGE; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

AGE FACTORS; ANTIBODIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MUSCLES; MYASTHENIA GRAVIS; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 0037573558     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-39605     Document Type: Letter

References (5)

1. Andrews PI, Massey JM, Sanders DB. Acetylcholine receptor antibodies in juvenile myasthenia gravis. Neurology 1993; 43: 977-982
2. Anlar B, Ozdirim E, Renda Y, Yalaz K, Aysun S, Topcu M, Topaloglu H. Myasthenia gravis in childhood. Acta Pediatr 1996; 85: 838-842
3. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001; 7: 365-368
4. Liyanage Y, Hoch W, Beeson D, Vincent A. The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction. Muscle Nerve 2002; 25: 4-16
5. Sanders DB, Andrews I, Howrad JF, Massey JM. Seronegative myasthenia gravis. Neurology 1997; 48 (Suppl 5): S40-S45